December 10th & 11th, 2026
15th edition
MARSEILLE, FR
Stand J9

2016 Edition

RD-BIOTECH

fr

RD-Biotech is a French CRO that proposed services in biotechnology:
Bioproduction: mAb, recombinant proteins, plasmids
Research contracts: cell line, hybridoma development, cloning, humanization, ELISA
Biotech Investissement, majority shareholder of RD-BIOTECH, acquired Diaclone SAS on 2012: a wide range of mAbs & Immunoassays
SynAbs, a Belgium company. Joined the Group last month. Its expertise in rat mAb greatly complement the expertise of the sister companies in the field of mAbs

Scroll to Top

Before you leave…

Download the official BioFIT 2026 brochure

Discover the conference programme, partnership opportunities, attendee profiles, registration options and everything you need to make the most of BioFIT 2026.